As a tumor suppressor, besides colorectal cancer, DCC defect was reported to contribute to the carcinogenesis in many other cancers, such as melanoma, breast, neuroblastoma and hematologic malignancies [23, 25]. This evidence concerns the gene DCC and neoplasm.